南華早報·商業· Xinmei Shen·· 4 hours agoAI score20
Two Cancer Vaccines Under Li Ka-shing's Sequencio Selected for Presentation at US SITC Meeting
2 cancer drugs from Li Ka-shing-backed Sequencio garner global attention
AI briefing
Two cancer vaccine candidates from CK Life Sciences' Sequencio Therapeutics, CKLS118 and CKLS202, have been selected for presentation of preclinical data on Friday at the Society for Immunotherapy of Cancer (SITC) meeting in Phoenix, Arizona. The company said it will present the relevant research findings at the meeting.
Source: 南華早報·商業 · scmp.com